40patientsonthecombinationtherapyofChineseandWesternmedicinetreatmentofovarianprematuresenilityAuthor:ZHANGAi-rongWangJuan,CAOFamily,ZhuYi[Abstract]ObjectiveToobservetheWesternprematureovarianfailure,40casesofclinicalefficacyofcombinationtherapytreatmentmethodto40casesofprematureovarianfailurewererandomlydividedintotwogroups.TreatmentgroupusingthetraditionalChinesemedicinecombinedwithwesternartificialcycletherapyraisedbythesoup,thecontrolgroupwithWesternartificialcycletherapymonthltreatment,observedatotalofthreecourses,observedchangesintheclinicalefficacyandserumE2,FSHandLHlevels.theresultsoftwogroupsofpatientswithserumE2weresignificantlyincreasedcomparedwithbeforetreatment,areverysignificantdifferences(allP<0.01);serumlevelsofFSHdecreasedsignificantlycomparedwithbeforetreatmentisasignificantdifference(P<0.01),serumlevelsofLHaftertreatmenthasdeclined,buttherewasnosignificant1difference(P>0.05),treatmentandcontrolgroups,thetotalefficiencyof95%and90%,respectively,showednosignificantdifference(P>0.05).withdrawalthreemonthsafterthetreatmentgroupandcontrolgroup,thetotalefficiencyrespectively.85%and60%,andWesternmedicinetherapyonserumhormonelevelsinpatientswithprematureovarianfailureandtheclinicalsymptomsaresignificantdifferences(P<0.01)ConclusionImprovementofadvantagescomparedwiththecontrolgroup,andthehighcurerate,relapseratelowefficacyandstability.Westernmedicinetherapyinprematureovarianfailure,raisedbyTangPrematureovarianfailure(PrematureOvarilureFailure,POF)referstoaclassofseriousimpactonwomen’sreproductivehealthandmentalandphysicalhealthoftheovarianfunctiondeclinediseasecausedbythewomenbeforetheageof40,forsomereason.Menarchebeforetheageof40lowestrogenandhighgonadotropinstatus,acommongynecologicalendocrinediseases.Inrecentyears,theincidenceofanupwardtrendyearbyyear,the2epidemiologicalsurvey,theratewas1%[1].patientswithhotflashes,sweating,facialflushing,lowlibido,lowestrogensymptomsofvaryingdegreesofself-applicationofChinesemedicineinJune2010June2011raisedbythesoupcombinedwithwesternartificialcycletreatmentofdisease,andcomparedwiththepurelyartificialcycletherapynowreportedbelow.1clinicaldata1.1GeneralinformationobservedinthisstudypatientswerefromtheAnqingCityHospitalgynecologyclinicinJune2010June2011diagnosisofprematureovarianfailure(kidneyyindeficiencysyndromepatients,observedatotalof40cases,40caseswererandomlydividedintotreatmentgroupwiththecontrolgroup,20patientsineachtreatmentgroup20cases,theageof28to37years,meanage32.5years,20casesinthecontrolgroup,theageof28to38yearsold,meanage33years.Allpatientsweremarried,amenorrhealifeof>=6months,andexclusionoftheanatomyofthereproductivetractmalformations,chromosomalabnormalities,consistentwithprematureovarianfailurediagnosticcriteriabetweenthetwogroups3inthegeneralinformation,thedifferencewassignificant(P>0.05)werecomparable.1.2Thediagnosticcriteriafortheageof40yearsofage,hadnormalmenstruation,amenorrheainJune,withorwithouthotflashes,nightsweatsandotherperimenopausalsymptoms,morethantwoserumFSH>40U/L,E2<25ng/L,PRLnormal(twoinspectionintervalsabove)inJanuary,completethewomb.Gettingridofourconditions:heart,liver,kidneyfunctionisseverelyabnormalorcombinedwithotherendocrinediseases.TCMkidneyamenorrhea,clinicalresearchguidingprincipleofamenorrhea>>StandardSee<<TraditionalChineseDrugResearch.Treatmentandobservationmethod2.1treatmentTr...